Alcon Secures FDA Approval For BRYTLY OTC Redness Relief Eye Drops

WASHINGTON (dpa-AFX) - Alcon (ALC, ALC.SW) announced that the U.S. Food and Drug Administration approved BRYTLY Redness Reliever Eye Drops, an over-the-counter treatment designed to reduce eye red...
This is a short summary. The full story is published by Finanznachrichten.de.
Read full story at Finanznachrichten.de